Skip to main content

Advertisement

Table 1 Effect of dopamine 1/5 receptor agonist treatment on skeletal muscle cAMP levels.

From: Activation of the dopamine 1 and dopamine 5 receptors increase skeletal muscle mass and force production under non-atrophying and atrophying conditions

Treatment Tibialis Anterior cAMP levels +/- SEM (femptomoles/mg) Medial Gastrocnemius cAMP levels +/- SEM (femptomoles/mg)
Theophylline 329.6 +/- 62.6 286.4 +/-58.8
SKF 81297 + theophylline 486.6 +/- 81.4* 535.3 +/-53.6*
  1. * - statistically significant (p < 0.05) versus theophylline.